BANK VONTOBEL/CALL/STRYKER CORP./300/0.1/21.06.24 Stock

Warrant

DE000VM576L6

Real-time Boerse Frankfurt Warrants 08:00:59 2024-06-11 am EDT
4.57 EUR +1.78% Intraday chart for BANK VONTOBEL/CALL/STRYKER CORP./300/0.1/21.06.24
Current month+16.62%
1 month+42.99%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-11 4.57 +1.78%
24-06-10 4.49 -4.67%
24-06-07 4.71 +5.13%
24-06-06 4.48 +2.99%
24-06-05 4.35 +7.41%

Real-time Boerse Frankfurt Warrants

Last update June 11, 2024 at 08:00 am EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying STRYKER CORPORATION
IssuerLogo Issuer Vontobel Vontobel
WKN VM576L
ISINDE000VM576L6
Date issued 2023-11-30
Strike 300 $
Maturity 2024-06-21 (10 Days)
Parity 10 : 1
Emission price 5.35
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 6.11
Lowest since issue 1.64
Spread 0.03
Spread %0.69%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
348.2 USD
Average target price
373.1 USD
Spread / Average Target
+7.15%
Consensus